Verinnogen

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

ScreenIn3D Limited

This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.

Veriskin

Veriskin develops a handheld medical device using artificial intelligence to help primary care providers non-invasively detect skin cancer during routine physical examinations.

Iscaff Pharma

This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.

Vortex Biotech

This company provides circulating tumour cell isolation systems for clinicians, researchers and pharmaceutical companies to support cancer diagnosis and patient monitoring.

Carcinotech

Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.

Nearwave

Nearwave develops handheld, non-invasive near-infrared imaging devices to help oncologists and clinical researchers monitor breast cancer treatment efficacy and assess deep tissue biomarkers.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.